![A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus
<i>nab</i>
‐Paclitaxel and Gemcitabine in Advanced Solid Tumors]()
A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus
<i>nab</i>
‐Paclitaxel and Gemcitabine in Advanced Solid TumorsBeatty, Gregory L.; Shahda, Safi; Beck, Thaddeus; Uppal, Nikhil; Cohen, Steven J.; Donehower, Ross; Gabayan, Afshin Eli; Assad, Albert; Switzky, Julie; Zhen, Huiling; Von Hoff, Daniel D. · The Oncologist · 2018